-
Patent Agency Ranking
公开(公告)号：US20160220659A1
公开(公告)日：2016-08-04
申请号：US14863181
申请日：2015-09-23
Applicant: MERIAL, INC.
Inventor： Jean-Christophe Audonnet , Zahia Hannas-Djebbara , Teshome Mebatsion , Yu-Wei Chiang , Justin Widener , Frédéric Reynard
IPC: A61K39/135 , C07K14/005 , C12N7/00
CPC classification number: A61K39/135 , A61K39/12 , A61K2039/5258 , A61K2039/545 , A61K2039/55577 , C07K14/005 , C12N7/00 , C12N2710/10043 , C12N2710/14043 , C12N2770/32123 , C12N2770/32134
Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
Abstract translation: 本发明包括FMDV疫苗或组合物。 疫苗或组合物可以是含有FMDV抗原的疫苗或组合物。 本发明还包括编码和表达FMDV抗原，表位或免疫原的重组载体，其可用于保护动物，特别是针对FMDV的动物，特别是羊，牛，cap或猪。
-
2.发明申请公开(公告)号：US20160120799A1
公开(公告)日：2016-05-05
申请号：US14930831
申请日：2015-11-03
Applicant: MERIAL, INC. , Georgia Tech Research Corporation
Inventor： Yu-Wei Chiang , Mark R. Prausnitz , Kristopher Daniel DeWitt , Jaya Arya
IPC: A61K9/00 , C12N7/00 , A61K39/205
CPC classification number: A61K9/0021 , A61B5/150984 , A61B17/20 , A61B17/205 , A61K39/12 , A61K39/205 , A61K2039/5254 , A61K2039/5256 , A61K2039/53 , A61K2039/54 , A61K2039/545 , A61K2039/552 , A61M37/0015 , A61M2037/0046 , A61M2037/0061 , C12N7/00 , C12N2760/20034 , C12N2760/20134
Abstract: The present invention relates to microneedle vaccine formulations, as well as methods of use thereof to provide animals, including canines, protective immunity against infection and disease caused by rabies viruses. Once placed onto the skin of the animals, the microneedle formulations dissolve quickly into the surrounding skin, where the antigens then elicit in the animals high and protective levels of rabies virus neutralizing antibodies.
Abstract translation: 本发明涉及微针疫苗制剂，以及其用于提供动物，包括犬科动物的保护性免疫和由狂犬病病毒引起的疾病的方法。 一旦放置在动物的皮肤上，微针制剂迅速溶解到周围的皮肤中，其中抗原然后在动物中引起高的保护水平的狂犬病病毒中和抗体。
-
公开(公告)号：US20180250382A1
公开(公告)日：2018-09-06
申请号：US15846735
申请日：2016-06-23
Applicant: MERIAL INC.
Inventor： Yu-Wei Chiang , David Cureton , Herve Poulet
IPC: A61K39/145 , A61P31/16 , G01N33/569
CPC classification number: A61K39/145 , A61K39/12 , A61K2039/5252 , A61K2039/552 , A61K2039/55505 , A61K2039/55566 , A61K2039/70 , A61P31/16 , C12N2760/16134 , G01N33/56983
Abstract: The present invention relates to canine influenza virus strains, and vaccines and compositions. The present invention also relates to reagents and methods allowing their detection, methods of vaccination as well as methods of producing these reagents and vaccines.
-
公开(公告)号：US10010605B2
公开(公告)日：2018-07-03
申请号：US14863181
申请日：2015-09-23
Applicant: MERIAL, INC.
Inventor： Jean-Christophe Audonnet , Zahia Hannas-Djebbara , Teshome Mebatsion , Yu-Wei Chiang , Justin Widener , Frédéric Reynard
IPC: A61K39/135 , A61K39/12 , C07K14/005 , C12N7/00 , A61K39/00
CPC classification number: A61K39/135 , A61K39/12 , A61K2039/5258 , A61K2039/545 , A61K2039/55577 , C07K14/005 , C12N7/00 , C12N2710/10043 , C12N2710/14043 , C12N2770/32123 , C12N2770/32134
Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
-
公开(公告)号：US10010499B2
公开(公告)日：2018-07-03
申请号：US14930831
申请日：2015-11-03
Applicant: MERIAL, INC. , Georgia Tech Research Corporation
Inventor： Yu-Wei Chiang , Mark R. Prausnitz , Kristopher Daniel DeWitt , Jaya Arya
CPC classification number: A61K9/0021 , A61B5/150984 , A61B17/20 , A61B17/205 , A61K39/12 , A61K39/205 , A61K2039/5254 , A61K2039/5256 , A61K2039/53 , A61K2039/54 , A61K2039/545 , A61K2039/552 , A61M37/0015 , A61M2037/0046 , A61M2037/0061 , C12N7/00 , C12N2760/20034 , C12N2760/20134
Abstract: The present invention relates to microneedle vaccine formulations, as well as methods of use thereof to provide animals, including canines, protective immunity against infection and disease caused by rabies viruses. Once placed onto the skin of the animals, the microneedle formulations dissolve quickly into the surrounding skin, where the antigens then elicit in the animals high and protective levels of rabies virus neutralizing antibodies.
-
-
-
-
Search Results
5
records
(took 0.018 seconds)
